KU Cancer Center Researchers Announce Study of High-Dose Intravenous Vitamin C to Treat Muscle-Invasive Bladder Cancer

Researchers at The University of Kansas Cancer Center have secured a $3.6 million grant from the US Department of Defense to study high-dose intravenous Vitamin C for treating muscle-invasive bladder cancer.